Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Yingjing
Contact Yingjing, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Recent Advances in Cycloaddition Reactions of Donor‐Acceptor Oxiranes via Carbon-Carbon Bond Cleavage
Conflicts of Interest There are no conflicts to declare. References 1, , , , , and , “The Anti-Angiogenic Agent Fumagillin Covalently Binds and Inhibits the Methionine Aminopeptidase, MetAP-2,” Proceedings National Academy of Science USA 94 (1997): 6099, https://doi.org/10.1073/pnas.94.12.6099. 2, , , et al., “Fumagillin Treatment of Hepatocellular Carcinoma in Rats: An In Vivo Study of Antiangiogenesis,” World Journal of Gastroenterology 11 (2005): 771, https://doi.org/10.3748/wjg.v11.i6.771.
Annulation via Ring Opening/Cyclization of Donor‐Acceptor Cyclobutanes with 2‐Naphthols: Access to Highly Functionalized Naphthalene‐Fused Oxepines
A mild and straightforward access to various substituted naphthalene-fused oxepines from readily available Donor-Acceptor (D-A) cyclobutanes is reported. This method involves the Lewis acid-catalyzed reactions of D-A cyclobutanes with 2-naphthols to afford ring-opened products, which can undergo intramolecular cyclization mediated by the NBS-base system to yield corresponding naphthalene-fused oxepines.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Yingjing
Contact Yingjing, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack